SceneRay Receives NMPA Approval for World-First DBS System Targeting Opioid Addiction
In a landmark development for the global neuromodulation market, the National Medical Products Administration (NMPA) has officially granted marketing approval to SceneRay Medical’s Implantable Deep...
